SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology ($MU) is experiencing significant volatility, as geopolitical tensions impacting the South Korean memory market clash with strong underlying demand for AI memory and recent analyst upgrades. While some investors perceive the pullback as a necessary correction, many in the community are actively buying the dip, anticipating robust earnings and Micron's strategic positioning in the high-bandwidth memory sector.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending amidst significant market volatility fueled by escalating geopolitical tensions in the Middle East, which are driving up oil prices and triggering circuit breakers in global markets. The community is sharply divided between those advocating to "buy the dip" and others expressing frustration over perceived market manipulation and the sustainability of current price action, even as government intervention aims to secure energy flows.

SSgA Active Trust - State Street SPDR Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF is trending as breaking reports of Iran's Supreme Leader being killed and subsequent negotiation offers ignite intense market volatility. The community is sharply divided between anticipating a short squeeze or a broader downturn, with ongoing concerns about oil prices and geopolitical instability driving widespread debate.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is highly volatile amid escalating Middle East tensions, fueling fears of rising oil prices and inflation, alongside market uncertainty over new tariffs and AI's impact on tech. The community is sharply divided between those bracing for further declines and aggressive dip-buyers anticipating a significant rally or short squeeze in the leveraged tech ETF.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is generating significant debate ahead of its imminent earnings report, as frustrated investors grapple with its continued decline to new 52-week lows, while others point to deep undervaluation and strong fundamentals amidst intense sector competition and geopolitical concerns.

BlackRock Institutional Trust Company N.A. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

EWY is trending as South Korea's market experienced a significant decline, triggering circuit breakers amid surging oil and LNG prices fueled by geopolitical tensions, which led to a massive sell-off in key semiconductor holdings like Samsung and SK Hynix; the community is actively debating whether this represents an excessive correction and a prime buying opportunity or a sign of an over-extended market.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

DJIA is trending amidst heightened geopolitical tensions, including ongoing developments in the Middle East and tariff discussions, which are driving broad market volatility. Community sentiment is sharply divided, with some expressing optimism for market resilience and potential gains, while others voice concerns about a broader economic downturn and market vulnerability.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

SOXL is seeing a tug-of-war in sentiment as traders weigh geopolitical tensions in the Middle East and upcoming Nvidia earnings against ongoing strong AI demand for semiconductors. The community is sharply divided, with some actively "buying the dip" and others warning of a significant pullback due to leveraged ETF decay and broader market uncertainty.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is experiencing a surge in attention due to escalating geopolitical tensions highlighting the critical role of drone technology in modern warfare. Community discussion is buzzing with expectations of a short squeeze and imminent results from the Drone Dominance Gauntlet program, which could further solidify the company's position in defense solutions.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is a hot topic following an earnings call that showcased robust ANKTIVA revenue growth and plans for immediate global product shipments, sparking community debate between long-term optimism for a cancer cure and short-term investor disappointment over financial guidance amidst active short-seller sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 12-Month Low After Analyst Downgrade

Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 1-Year Low on Analyst Downgrade...

Amphastar Pharmaceuticals (NASDAQ:AMPH) Issues Quarterly Earnings Results

Amphastar Pharmaceuticals (NASDAQ:AMPH - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.73 earnings per share (EPS) for the quarter, missing the consensus...

Wells Fargo & Company Has Lowered Expectations for Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price

Wells Fargo & Company decreased their target price on shares of Amphastar Pharmaceuticals from $34.00 to $30.00 and set an "overweight" rating for the company in a research note on Friday...

Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Down Following Analyst Downgrade

Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Down on Analyst Downgrade...

Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target Lowered to $30.00 at Needham & Company LLC

Needham & Company LLC dropped their price objective on shares of Amphastar Pharmaceuticals from $34.00 to $30.00 and set a "buy" rating for the company in a report on Friday...

TD Asset Management Inc Sells 103,038 Shares of Amphastar Pharmaceuticals, Inc. $AMPH

TD Asset Management Inc decreased its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 5.1% in the third quarter, according to the company in its most recent 13F filing with...

Amphastar Pharmaceuticals Q4 Earnings Call Highlights

Amphastar Pharmaceuticals (NASDAQ:AMPH) executives on the company's fourth-quarter earnings call highlighted new FDA approvals, continued growth for BAQSIMI, and expectations for mid-to-high...

Compared to Estimates, Amphastar (AMPH) Q4 Earnings: A Look at Key Metrics

Although the revenue and EPS for Amphastar (AMPH) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates

Amphastar (AMPH) delivered earnings and revenue surprises of -24.49% and -5.63%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings?

CorMedix heads into Q4 earnings with DefenCath sales, Melinta product contributions, and its muted 2026 guidance firmly in focus.

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Current Price	$19.83
Prev Close	$21.01
Open	$20.35
Dividend Yield	0.00%
50-Day Moving Average	$27.09
Beta	0.77
Avg. Volume	475,604.32
PE Ratio	10.33

52-Week High	$31.26
52-Week Low	$19.83
Market Capitalization	$1.12B
EPS (Annual)	$2.03
Price to Book	1.22
Revenue Per Employee	$364,315.28

AMPH
Amphastar Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AMPH News

AMPHAmphastar Pharmaceuticals Inc